Northwest Biotherapeutics reported 312.32M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Applied Genetic Technologies AGTC:US $ 21.71M 2M
AstraZeneca AZN:LN 23649M 1427M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Celldex Therapeutics CLDX:US $ 14.18M 0.31M
Cti Biopharma CTIC:US $ 62.34M 46.55M
Cytori Therapeutics CYTX:US $ 9.49M 1.13M
Cytrx CYTR:US 2.79M 301.42K
Eisai 4523:JP Y 280829M 2895M
Genocea Biosciences GNCA:US $ 14.7M 0.13M
Infinity Pharmaceuticals INFI:US $ 12.35M 1.8M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Northwest Biotherapeutics NWBO:US 312.32M 48.39M
Sunesis Pharmaceuticals SNSS:US $ 7.16M 0.21M